Column Group LLC - Stock Holdings in 13F Filings (SEC)

Updated on March 15, 2026.

Based on 13F Filings filed with the SEC on February 13, 2026, for the 2025 Q4 period, Column Group LLC held in its portfolio 5 assets valued at $82,793,614 (i.e. $82.79M).

The most valuable assets in the portfolio included: Surrozen, Inc. ($41.84M), ORIC Pharmaceuticals Inc. ($28.96M), and Tenaya Therapeutics, Inc. ($6.69M).

The chart below shows the top 5 valuable assets, and the table below shows the top 5 valuable assets.

You can see similar for other investment managers.

Related Topics: SEC Topic List.

Data Source: SEC.

Top Valuable Stocks in Column Group LLC Portfolio

Surrozen, Inc.

ORIC Pharmaceuticals Inc.

Tenaya Therapeutics, Inc.

RAPT Therapeutics Inc

Revolution Medicines Inc

Column Group LLC - Stock Holdings in 13F Filings (SEC)

Items per page:

0 of 0

Name of Issuer	No. of Shares	Value ($)	Class
Surrozen, Inc.	1851350	41840510	COM
ORIC Pharmaceuticals Inc.	3540777	28963556	COM
Tenaya Therapeutics, Inc.	9400290	6693006	COM
RAPT Therapeutics Inc	156270	5292878	COM
Revolution Medicines Inc	46	3664	COM